Global Japanese Encephalitis Inactivated Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Japanese Encephalitis Inactivated Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Japanese Encephalitis Inactivated Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Japanese Encephalitis Inactivated Vaccine that contribute to its increasing demand across many markets.
The global Japanese Encephalitis Inactivated Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Japanese Encephalitis Inactivated Vaccine total production and demand, 2017-2028, (K Units)
Global Japanese Encephalitis Inactivated Vaccine total production value, 2017-2028, (USD Million)
Global Japanese Encephalitis Inactivated Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Japanese Encephalitis Inactivated Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Japanese Encephalitis Inactivated Vaccine domestic production, consumption, key domestic manufacturers and share
Global Japanese Encephalitis Inactivated Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Japanese Encephalitis Inactivated Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Japanese Encephalitis Inactivated Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Japanese Encephalitis Inactivated Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Japanese Encephalitis Inactivated Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Japanese Encephalitis Inactivated Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Japanese Encephalitis Inactivated Vaccine Market, By Region:
1. How big is the global Japanese Encephalitis Inactivated Vaccine market?
2. What is the demand of the global Japanese Encephalitis Inactivated Vaccine market?
3. What is the year over year growth of the global Japanese Encephalitis Inactivated Vaccine market?
4. What is the production and production value of the global Japanese Encephalitis Inactivated Vaccine market?
5. Who are the key producers in the global Japanese Encephalitis Inactivated Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Japanese Encephalitis Inactivated Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Japanese Encephalitis Inactivated Vaccine that contribute to its increasing demand across many markets.
The global Japanese Encephalitis Inactivated Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Japanese Encephalitis Inactivated Vaccine total production and demand, 2017-2028, (K Units)
Global Japanese Encephalitis Inactivated Vaccine total production value, 2017-2028, (USD Million)
Global Japanese Encephalitis Inactivated Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Japanese Encephalitis Inactivated Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Japanese Encephalitis Inactivated Vaccine domestic production, consumption, key domestic manufacturers and share
Global Japanese Encephalitis Inactivated Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Japanese Encephalitis Inactivated Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Japanese Encephalitis Inactivated Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Japanese Encephalitis Inactivated Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Japanese Encephalitis Inactivated Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Japanese Encephalitis Inactivated Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Japanese Encephalitis Inactivated Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Adult
- Child
- Hospital
- Clinic
- Valneva
- Sanofi Pasteur
- Biken
- Lanzhou Institute of Biological Products Co., Ltd
- Liaoning Chengda Biological Co., Ltd
- Beijing Institute of Biological Products Co., Ltd
- Chengdu Institute of Biological Products Co., Ltd
1. How big is the global Japanese Encephalitis Inactivated Vaccine market?
2. What is the demand of the global Japanese Encephalitis Inactivated Vaccine market?
3. What is the year over year growth of the global Japanese Encephalitis Inactivated Vaccine market?
4. What is the production and production value of the global Japanese Encephalitis Inactivated Vaccine market?
5. Who are the key producers in the global Japanese Encephalitis Inactivated Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Japanese Encephalitis Inactivated Vaccine Introduction
1.2 World Japanese Encephalitis Inactivated Vaccine Supply & Forecast
1.2.1 World Japanese Encephalitis Inactivated Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.2.3 World Japanese Encephalitis Inactivated Vaccine Pricing Trends (2017-2028)
1.3 World Japanese Encephalitis Inactivated Vaccine Production by Region
1.3.1 World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2017-2028)
1.3.2 World Japanese Encephalitis Inactivated Vaccine Production by Region (2017-2028)
1.3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Region (2017-2028)
1.3.4 North America Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.3.5 Europe Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.3.6 China Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.3.7 Japan Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Japanese Encephalitis Inactivated Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Japanese Encephalitis Inactivated Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Japanese Encephalitis Inactivated Vaccine Demand (2017-2028)
2.2 World Japanese Encephalitis Inactivated Vaccine Consumption by Region
2.2.1 World Japanese Encephalitis Inactivated Vaccine Consumption by Region (2017-2022)
2.2.2 World Japanese Encephalitis Inactivated Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.4 China Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.5 Europe Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.6 Japan Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.7 South Korea Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.8 ASEAN Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.9 India Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
3 WORLD JAPANESE ENCEPHALITIS INACTIVATED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Japanese Encephalitis Inactivated Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Japanese Encephalitis Inactivated Vaccine Production by Manufacturer (2017-2022)
3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Japanese Encephalitis Inactivated Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Japanese Encephalitis Inactivated Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Japanese Encephalitis Inactivated Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Japanese Encephalitis Inactivated Vaccine in 2021
3.6 Japanese Encephalitis Inactivated Vaccine Market: Overall Company Footprint Analysis
3.6.1 Japanese Encephalitis Inactivated Vaccine Market: Region Footprint
3.6.2 Japanese Encephalitis Inactivated Vaccine Market: Company Product Type Footprint
3.6.3 Japanese Encephalitis Inactivated Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Comparison
4.1.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Comparison
4.2.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Comparison
4.3.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Japanese Encephalitis Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Japanese Encephalitis Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Japanese Encephalitis Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Japanese Encephalitis Inactivated Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Adult
5.2.2 Child
5.3 Market Segment by Type
5.3.1 World Japanese Encephalitis Inactivated Vaccine Production by Type (2017-2028)
5.3.2 World Japanese Encephalitis Inactivated Vaccine Production Value by Type (2017-2028)
5.3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Japanese Encephalitis Inactivated Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Japanese Encephalitis Inactivated Vaccine Production by Application (2017-2028)
6.3.2 World Japanese Encephalitis Inactivated Vaccine Production Value by Application (2017-2028)
6.3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Valneva
7.1.1 Valneva Details
7.1.2 Valneva Major Business
7.1.3 Valneva Japanese Encephalitis Inactivated Vaccine Product and Services
7.1.4 Valneva Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Valneva Recent Developments/Updates
7.1.6 Valneva Competitive Strengths & Weaknesses
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Details
7.2.2 Sanofi Pasteur Major Business
7.2.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product and Services
7.2.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Sanofi Pasteur Recent Developments/Updates
7.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.3 Biken
7.3.1 Biken Details
7.3.2 Biken Major Business
7.3.3 Biken Japanese Encephalitis Inactivated Vaccine Product and Services
7.3.4 Biken Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biken Recent Developments/Updates
7.3.6 Biken Competitive Strengths & Weaknesses
7.4 Lanzhou Institute of Biological Products Co., Ltd
7.4.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.4.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.4.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.4.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.4.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.5 Liaoning Chengda Biological Co., Ltd
7.5.1 Liaoning Chengda Biological Co., Ltd Details
7.5.2 Liaoning Chengda Biological Co., Ltd Major Business
7.5.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.5.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Liaoning Chengda Biological Co., Ltd Recent Developments/Updates
7.5.6 Liaoning Chengda Biological Co., Ltd Competitive Strengths & Weaknesses
7.6 Beijing Institute of Biological Products Co., Ltd
7.6.1 Beijing Institute of Biological Products Co., Ltd Details
7.6.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.6.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.6.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.6.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.7 Chengdu Institute of Biological Products Co., Ltd
7.7.1 Chengdu Institute of Biological Products Co., Ltd Details
7.7.2 Chengdu Institute of Biological Products Co., Ltd Major Business
7.7.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.7.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
7.7.6 Chengdu Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Japanese Encephalitis Inactivated Vaccine and Key Manufacturers
8.2 Japanese Encephalitis Inactivated Vaccine Manufacturing Costs
8.3 Japanese Encephalitis Inactivated Vaccine Production Process
8.4 Japanese Encephalitis Inactivated Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Japanese Encephalitis Inactivated Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Japanese Encephalitis Inactivated Vaccine Typical Distributors
9.3 Japanese Encephalitis Inactivated Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Japanese Encephalitis Inactivated Vaccine Introduction
1.2 World Japanese Encephalitis Inactivated Vaccine Supply & Forecast
1.2.1 World Japanese Encephalitis Inactivated Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.2.3 World Japanese Encephalitis Inactivated Vaccine Pricing Trends (2017-2028)
1.3 World Japanese Encephalitis Inactivated Vaccine Production by Region
1.3.1 World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2017-2028)
1.3.2 World Japanese Encephalitis Inactivated Vaccine Production by Region (2017-2028)
1.3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Region (2017-2028)
1.3.4 North America Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.3.5 Europe Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.3.6 China Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.3.7 Japan Japanese Encephalitis Inactivated Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Japanese Encephalitis Inactivated Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Japanese Encephalitis Inactivated Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Japanese Encephalitis Inactivated Vaccine Demand (2017-2028)
2.2 World Japanese Encephalitis Inactivated Vaccine Consumption by Region
2.2.1 World Japanese Encephalitis Inactivated Vaccine Consumption by Region (2017-2022)
2.2.2 World Japanese Encephalitis Inactivated Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.4 China Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.5 Europe Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.6 Japan Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.7 South Korea Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.8 ASEAN Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
2.9 India Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028)
3 WORLD JAPANESE ENCEPHALITIS INACTIVATED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Japanese Encephalitis Inactivated Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Japanese Encephalitis Inactivated Vaccine Production by Manufacturer (2017-2022)
3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Japanese Encephalitis Inactivated Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Japanese Encephalitis Inactivated Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Japanese Encephalitis Inactivated Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Japanese Encephalitis Inactivated Vaccine in 2021
3.6 Japanese Encephalitis Inactivated Vaccine Market: Overall Company Footprint Analysis
3.6.1 Japanese Encephalitis Inactivated Vaccine Market: Region Footprint
3.6.2 Japanese Encephalitis Inactivated Vaccine Market: Company Product Type Footprint
3.6.3 Japanese Encephalitis Inactivated Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Comparison
4.1.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Comparison
4.2.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Comparison
4.3.1 United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Japanese Encephalitis Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Japanese Encephalitis Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Japanese Encephalitis Inactivated Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Japanese Encephalitis Inactivated Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Adult
5.2.2 Child
5.3 Market Segment by Type
5.3.1 World Japanese Encephalitis Inactivated Vaccine Production by Type (2017-2028)
5.3.2 World Japanese Encephalitis Inactivated Vaccine Production Value by Type (2017-2028)
5.3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Japanese Encephalitis Inactivated Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Japanese Encephalitis Inactivated Vaccine Production by Application (2017-2028)
6.3.2 World Japanese Encephalitis Inactivated Vaccine Production Value by Application (2017-2028)
6.3.3 World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Valneva
7.1.1 Valneva Details
7.1.2 Valneva Major Business
7.1.3 Valneva Japanese Encephalitis Inactivated Vaccine Product and Services
7.1.4 Valneva Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Valneva Recent Developments/Updates
7.1.6 Valneva Competitive Strengths & Weaknesses
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Details
7.2.2 Sanofi Pasteur Major Business
7.2.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product and Services
7.2.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Sanofi Pasteur Recent Developments/Updates
7.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.3 Biken
7.3.1 Biken Details
7.3.2 Biken Major Business
7.3.3 Biken Japanese Encephalitis Inactivated Vaccine Product and Services
7.3.4 Biken Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biken Recent Developments/Updates
7.3.6 Biken Competitive Strengths & Weaknesses
7.4 Lanzhou Institute of Biological Products Co., Ltd
7.4.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.4.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.4.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.4.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.4.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.5 Liaoning Chengda Biological Co., Ltd
7.5.1 Liaoning Chengda Biological Co., Ltd Details
7.5.2 Liaoning Chengda Biological Co., Ltd Major Business
7.5.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.5.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Liaoning Chengda Biological Co., Ltd Recent Developments/Updates
7.5.6 Liaoning Chengda Biological Co., Ltd Competitive Strengths & Weaknesses
7.6 Beijing Institute of Biological Products Co., Ltd
7.6.1 Beijing Institute of Biological Products Co., Ltd Details
7.6.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.6.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.6.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.6.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.7 Chengdu Institute of Biological Products Co., Ltd
7.7.1 Chengdu Institute of Biological Products Co., Ltd Details
7.7.2 Chengdu Institute of Biological Products Co., Ltd Major Business
7.7.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
7.7.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
7.7.6 Chengdu Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Japanese Encephalitis Inactivated Vaccine and Key Manufacturers
8.2 Japanese Encephalitis Inactivated Vaccine Manufacturing Costs
8.3 Japanese Encephalitis Inactivated Vaccine Production Process
8.4 Japanese Encephalitis Inactivated Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Japanese Encephalitis Inactivated Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Japanese Encephalitis Inactivated Vaccine Typical Distributors
9.3 Japanese Encephalitis Inactivated Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Japanese Encephalitis Inactivated Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Japanese Encephalitis Inactivated Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Region (2017-2022)
Table 9. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Region (2023-2028)
Table 10. World Japanese Encephalitis Inactivated Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Japanese Encephalitis Inactivated Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Japanese Encephalitis Inactivated Vaccine Major Market Trends
Table 13. World Japanese Encephalitis Inactivated Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Japanese Encephalitis Inactivated Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Japanese Encephalitis Inactivated Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Japanese Encephalitis Inactivated Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Japanese Encephalitis Inactivated Vaccine Producers in 2021
Table 18. World Japanese Encephalitis Inactivated Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Japanese Encephalitis Inactivated Vaccine Producers in 2021
Table 20. World Japanese Encephalitis Inactivated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Japanese Encephalitis Inactivated Vaccine Company Evaluation Quadrant
Table 22. World Japanese Encephalitis Inactivated Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Japanese Encephalitis Inactivated Vaccine Production Site of Key Manufacturer
Table 24. Japanese Encephalitis Inactivated Vaccine Market: Company Product Type Footprint
Table 25. Japanese Encephalitis Inactivated Vaccine Market: Company Product Application Footprint
Table 26. Japanese Encephalitis Inactivated Vaccine Competitive Factors
Table 27. Japanese Encephalitis Inactivated Vaccine New Entrant and Capacity Expansion Plans
Table 28. Japanese Encephalitis Inactivated Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Japanese Encephalitis Inactivated Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Japanese Encephalitis Inactivated Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Japanese Encephalitis Inactivated Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Japanese Encephalitis Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Japanese Encephalitis Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Japanese Encephalitis Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Japanese Encephalitis Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Japanese Encephalitis Inactivated Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Japanese Encephalitis Inactivated Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Japanese Encephalitis Inactivated Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Japanese Encephalitis Inactivated Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Japanese Encephalitis Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Japanese Encephalitis Inactivated Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Japanese Encephalitis Inactivated Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Japanese Encephalitis Inactivated Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Japanese Encephalitis Inactivated Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Valneva Basic Information, Manufacturing Base and Competitors
Table 62. Valneva Major Business
Table 63. Valneva Japanese Encephalitis Inactivated Vaccine Product and Services
Table 64. Valneva Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Valneva Recent Developments/Updates
Table 66. Valneva Competitive Strengths & Weaknesses
Table 67. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Pasteur Major Business
Table 69. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product and Services
Table 70. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Sanofi Pasteur Recent Developments/Updates
Table 72. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 73. Biken Basic Information, Manufacturing Base and Competitors
Table 74. Biken Major Business
Table 75. Biken Japanese Encephalitis Inactivated Vaccine Product and Services
Table 76. Biken Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biken Recent Developments/Updates
Table 78. Biken Competitive Strengths & Weaknesses
Table 79. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 81. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 82. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 84. Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 85. Liaoning Chengda Biological Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Liaoning Chengda Biological Co., Ltd Major Business
Table 87. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 88. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Liaoning Chengda Biological Co., Ltd Recent Developments/Updates
Table 90. Liaoning Chengda Biological Co., Ltd Competitive Strengths & Weaknesses
Table 91. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Institute of Biological Products Co., Ltd Major Business
Table 93. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 94. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 96. Chengdu Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 97. Chengdu Institute of Biological Products Co., Ltd Major Business
Table 98. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 99. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 100. Japanese Encephalitis Inactivated Vaccine Raw Material
Table 101. Key Manufacturers of Japanese Encephalitis Inactivated Vaccine Raw Materials
Table 102. Japanese Encephalitis Inactivated Vaccine Typical Distributors
Table 103. Japanese Encephalitis Inactivated Vaccine Typical Customers
Table 1. World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Japanese Encephalitis Inactivated Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Japanese Encephalitis Inactivated Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Japanese Encephalitis Inactivated Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Region (2017-2022)
Table 9. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Region (2023-2028)
Table 10. World Japanese Encephalitis Inactivated Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Japanese Encephalitis Inactivated Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Japanese Encephalitis Inactivated Vaccine Major Market Trends
Table 13. World Japanese Encephalitis Inactivated Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Japanese Encephalitis Inactivated Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Japanese Encephalitis Inactivated Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Japanese Encephalitis Inactivated Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Japanese Encephalitis Inactivated Vaccine Producers in 2021
Table 18. World Japanese Encephalitis Inactivated Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Japanese Encephalitis Inactivated Vaccine Producers in 2021
Table 20. World Japanese Encephalitis Inactivated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Japanese Encephalitis Inactivated Vaccine Company Evaluation Quadrant
Table 22. World Japanese Encephalitis Inactivated Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Japanese Encephalitis Inactivated Vaccine Production Site of Key Manufacturer
Table 24. Japanese Encephalitis Inactivated Vaccine Market: Company Product Type Footprint
Table 25. Japanese Encephalitis Inactivated Vaccine Market: Company Product Application Footprint
Table 26. Japanese Encephalitis Inactivated Vaccine Competitive Factors
Table 27. Japanese Encephalitis Inactivated Vaccine New Entrant and Capacity Expansion Plans
Table 28. Japanese Encephalitis Inactivated Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Japanese Encephalitis Inactivated Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Japanese Encephalitis Inactivated Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Japanese Encephalitis Inactivated Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Japanese Encephalitis Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Japanese Encephalitis Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Japanese Encephalitis Inactivated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Japanese Encephalitis Inactivated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Japanese Encephalitis Inactivated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Japanese Encephalitis Inactivated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Japanese Encephalitis Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Japanese Encephalitis Inactivated Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Japanese Encephalitis Inactivated Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Japanese Encephalitis Inactivated Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Japanese Encephalitis Inactivated Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Japanese Encephalitis Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Japanese Encephalitis Inactivated Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Japanese Encephalitis Inactivated Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Japanese Encephalitis Inactivated Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Japanese Encephalitis Inactivated Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Valneva Basic Information, Manufacturing Base and Competitors
Table 62. Valneva Major Business
Table 63. Valneva Japanese Encephalitis Inactivated Vaccine Product and Services
Table 64. Valneva Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Valneva Recent Developments/Updates
Table 66. Valneva Competitive Strengths & Weaknesses
Table 67. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Pasteur Major Business
Table 69. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product and Services
Table 70. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Sanofi Pasteur Recent Developments/Updates
Table 72. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 73. Biken Basic Information, Manufacturing Base and Competitors
Table 74. Biken Major Business
Table 75. Biken Japanese Encephalitis Inactivated Vaccine Product and Services
Table 76. Biken Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biken Recent Developments/Updates
Table 78. Biken Competitive Strengths & Weaknesses
Table 79. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 81. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 82. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 84. Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 85. Liaoning Chengda Biological Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Liaoning Chengda Biological Co., Ltd Major Business
Table 87. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 88. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Liaoning Chengda Biological Co., Ltd Recent Developments/Updates
Table 90. Liaoning Chengda Biological Co., Ltd Competitive Strengths & Weaknesses
Table 91. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Institute of Biological Products Co., Ltd Major Business
Table 93. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 94. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 96. Chengdu Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 97. Chengdu Institute of Biological Products Co., Ltd Major Business
Table 98. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product and Services
Table 99. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 100. Japanese Encephalitis Inactivated Vaccine Raw Material
Table 101. Key Manufacturers of Japanese Encephalitis Inactivated Vaccine Raw Materials
Table 102. Japanese Encephalitis Inactivated Vaccine Typical Distributors
Table 103. Japanese Encephalitis Inactivated Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Japanese Encephalitis Inactivated Vaccine Picture
Figure 2. World Japanese Encephalitis Inactivated Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Japanese Encephalitis Inactivated Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 5. World Japanese Encephalitis Inactivated Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 10. China Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 12. Japanese Encephalitis Inactivated Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Japanese Encephalitis Inactivated Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Japanese Encephalitis Inactivated Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Japanese Encephalitis Inactivated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Japanese Encephalitis Inactivated Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Japanese Encephalitis Inactivated Vaccine Markets in 2021
Figure 26. United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Japanese Encephalitis Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Japanese Encephalitis Inactivated Vaccine in United States
Figure 30. Key Producers and Market Share of Japanese Encephalitis Inactivated Vaccine in China
Figure 31. Key Producers and Market Share of Japanese Encephalitis Inactivated Vaccine in Rest of World
Figure 32. World Japanese Encephalitis Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Type in 2021
Figure 34. Adult
Figure 35. Child
Figure 36. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Japanese Encephalitis Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Japanese Encephalitis Inactivated Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
Figure 48. Japanese Encephalitis Inactivated Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Japanese Encephalitis Inactivated Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Japanese Encephalitis Inactivated Vaccine Picture
Figure 2. World Japanese Encephalitis Inactivated Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Japanese Encephalitis Inactivated Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 5. World Japanese Encephalitis Inactivated Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 10. China Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Japanese Encephalitis Inactivated Vaccine Production (2017-2028) & (K Units)
Figure 12. Japanese Encephalitis Inactivated Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Japanese Encephalitis Inactivated Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Japanese Encephalitis Inactivated Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Japanese Encephalitis Inactivated Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Japanese Encephalitis Inactivated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Japanese Encephalitis Inactivated Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Japanese Encephalitis Inactivated Vaccine Markets in 2021
Figure 26. United States VS China: Japanese Encephalitis Inactivated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Japanese Encephalitis Inactivated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Japanese Encephalitis Inactivated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Japanese Encephalitis Inactivated Vaccine in United States
Figure 30. Key Producers and Market Share of Japanese Encephalitis Inactivated Vaccine in China
Figure 31. Key Producers and Market Share of Japanese Encephalitis Inactivated Vaccine in Rest of World
Figure 32. World Japanese Encephalitis Inactivated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Type in 2021
Figure 34. Adult
Figure 35. Child
Figure 36. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Japanese Encephalitis Inactivated Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Japanese Encephalitis Inactivated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Japanese Encephalitis Inactivated Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Japanese Encephalitis Inactivated Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Japanese Encephalitis Inactivated Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Japanese Encephalitis Inactivated Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
Figure 48. Japanese Encephalitis Inactivated Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Japanese Encephalitis Inactivated Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
